Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized, Double-blind, Placebo Controlled, Parallel-group Study of CD07743 for the Improvement of Lateral Canthal Lines (Crow's Feet)

NCT01308060 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01308060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01308060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized, Double-blind, Placebo Controlled, Parallel-group Study of CD07743 for the Improvement of Lateral Canthal Lines (Crow's Feet)
Lead sponsor
Galderma R&D
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2011
Completion date
May 31, 2012
Enrollment
335 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

canthal lines